Suicidal Depression

Seelos Therapeutics Inc (NASDAQ: SEEL) has announced data from Part 1, the open-label cohort, of its Proof-of-Concept study of SLS-002 for acute suicidal ideation and behavior in patients with Major Depressive Disorder. On depression scale, 76.5% response rate on Day 1 (n=17),...

Moody’s Analytics chief economist Mark Zandi has warned that the U.S. economy risks a depression should individual states gamble on reopening businesses too soon. Make Or Break Moment Zandi, who sits on the board of MGIC, one of the largest private mortgage insurance companies, appeared...